Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Amylyx Pharmaceuticals Inc shares valued at $125,046 were sold by Mazzariello Gina on Aug 13 ’25. At $8.34 per share, Mazzariello Gina sold 15,000 shares. The insider’s holdings dropped to 156,969 shares worth approximately $1.48 million following the completion of this transaction.
Also, Mazzariello Gina sold 15,000 shares, netting a total of over 121,102 in proceeds. Following the sale of shares at $8.07 each, the insider now holds 171,969 shares.
Before that, GINA MAZZARIELLO had added 30,000 shares to its account. In a trade valued at $234,600, the Officer bought Amylyx Pharmaceuticals Inc shares for $7.82 each.
Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in late June. As of June 17, 2025, Citigroup has initiated its “Buy” rating for AMLX. Earlier on May 30, 2025, TD Cowen initiated its rating. Their recommendation was “a Buy” for AMLX stock.
Analyzing AMLX Stock Performance
On last trading session, Amylyx Pharmaceuticals Inc [NASDAQ: AMLX] plunged -0.32% to $9.42. The stock’s lowest price that day was $9.29, but it reached a high of $9.72 in the same session. During the last five days, there has been a surge of approximately 11.74%. Over the course of the year, Amylyx Pharmaceuticals Inc shares have jumped approximately 326.24%. Shares of the company reached a 52-week high of $9.72 on 08/28/25 and a 52-week low of $2.60 on 03/04/25.
Support And Resistance Levels for Amylyx Pharmaceuticals Inc (AMLX)
According to the 24-hour chart, there is a support level at 9.23, which, if violated, would cause prices to drop to 9.05. In the upper region, resistance lies at 9.66. The next price resistance is at 9.91. RSI (Relative Strength Index) is 64.66 on the 14-day chart, showing neutral technical sentiment.
Is Amylyx Pharmaceuticals Inc subject to short interest?
Stocks of Amylyx Pharmaceuticals Inc saw a sharp steep in short interest on 2025-08-15 dropping by 33003.0 shares to 7.43 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 7.47 million shares. A decline of -0.44% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 6.7 of the overall float, the days-to-cover ratio (short ratio) decline to 6.7.
Which companies own the most shares of Amylyx Pharmaceuticals Inc (AMLX)?
In terms of Amylyx Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 13.5 in the next 12 months, up nearly 42.86% from the previous closing price of $9.45. Analysts anticipate Amylyx Pharmaceuticals Inc stock to reach 17 by 2025, with the lowest price target being 10. In spite of this, 3 analysts ranked Amylyx Pharmaceuticals Inc stock as Buy at the end of 2025. On April 07, 2025, Mizuho assigned a price target of “an Outperform” to the stock and upgraded coverage with a $7.
